The 1st International Congress on Gene Therapy and Cell Therapy is a pioneering scientific event aimed at addressing the latest breakthroughs, challenges, and future directions in the rapidly evolving fields of gene- and cell-based therapeutics.
The vision of the 1st International Congress on Gene Therapy and Cell Therapy is to establish a dynamic, interdisciplinary, and globally connected platform that accelerates the development, translation, and clinical implementation of advanced gene and cell-based therapies.
Sharing the latest advances in gene and cell therapy at this congress plays a key role in advancing science and patient care.
4.5*Ardeshir Ghavamzadeh President of Congress
Providing a platform for scientific dialogue and synergy is a vital step towards developing innovative therapeutic technologies.
4.5*Maryam Barkhordar Scientific Secretary of the Congress
The convergence of scientists and experts paves the way for innovation and improvement in gene and cell therapy methods.
4.5*Majid Mesgartehrani Member of the Policy Council
Gene.
Cell.
Therapy.
Regeneration.
Engineering.
Innovation.
Global Gene & Cell Therapy Statistics
Gene & Cell Therapies in Development
k
Approved Gene & Cell Therapy Products
Global Gene Therapy Market Value (2024)
B$
Projected Gene & Cell Therapy Market (2034)
B$
Annual Global Gene Therapy Spending
B$
Congress Process
Scientific Pathway at the 1st
GC Congress
01Step
Registration & Submission
Participants submit their scientific papers in gene and cell therapy fields.
02Step
Peer Review Process
All submissions are reviewed by expert national and international referees.
03Step
Virtual Congress Sessions
Presentations and keynote speeches will be held virtually in specialized panels.
04Step
Publication of Results
Selected papers will be published in reputable scientific journals and widely announced.
The International Congress on Gene and Cell Therapy provides an ideal platform for sharing cutting-edge research and fostering collaboration among top international and national scientists in this field.